CENTESA Trademark

Trademark Overview


On Thursday, August 15, 2019, a trademark application was filed for CENTESA with the United States Patent and Trademark Office. The USPTO has given the CENTESA trademark a serial number of 88580529. The federal status of this trademark filing is CANCELLED - SECTION 18 as of Wednesday, November 6, 2024. This trademark is owned by Amazentis SA. The CENTESA trademark is filed in the Computer & Software Services & Scientific Services and Pharmaceutical Products categories with the following description:

House mark for pharmaceuticals for the treatment of mitochondrial diseases, disorders, and conditions, cardiovascular diseases, disorders, and conditions, musculoskeletal diseases, disorders, and conditions, neurodegenerative diseases, disorders, and conditions, oncological diseases, disorders, and conditions, metabolic diseases, disorders, and conditions, and diseases, disorders, and conditions related to aging

Research and development of pharmaceuticals in the fields of mitochondrial diseases, disorders, and conditions, cardiovascular diseases, disorders, and conditions, musculoskeletal diseases, disorders, and conditions, neurodegenerative diseases, disorders, and conditions, oncological diseases, disorders, and conditions, metabolic diseases, disorders, and conditions, and diseases, disorders, and conditions related to aging
centesa

General Information


Serial Number88580529
Word MarkCENTESA
Filing DateThursday, August 15, 2019
Status713 - CANCELLED - SECTION 18
Status DateWednesday, November 6, 2024
Registration Number6325129
Registration DateTuesday, April 20, 2021
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 2, 2021

Trademark Statements


Goods and ServicesHouse mark for pharmaceuticals for the treatment of mitochondrial diseases, disorders, and conditions, cardiovascular diseases, disorders, and conditions, musculoskeletal diseases, disorders, and conditions, neurodegenerative diseases, disorders, and conditions, oncological diseases, disorders, and conditions, metabolic diseases, disorders, and conditions, and diseases, disorders, and conditions related to aging
Goods and ServicesResearch and development of pharmaceuticals in the fields of mitochondrial diseases, disorders, and conditions, cardiovascular diseases, disorders, and conditions, musculoskeletal diseases, disorders, and conditions, neurodegenerative diseases, disorders, and conditions, oncological diseases, disorders, and conditions, metabolic diseases, disorders, and conditions, and diseases, disorders, and conditions related to aging

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code3 - Sec. 18 - Entire Registration
Class Status DateWednesday, November 6, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code3 - Sec. 18 - Entire Registration
Class Status DateWednesday, November 6, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAmazentis SA
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressEcublens 1024
CH

Party NameAmazentis SA
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressEcublens 1024
CH

Party NameAmazentis SA
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressEcublens 1024
CH

Trademark Events


Event DateEvent Description
Monday, September 16, 2024CANCELLATION GRANTED NO. 999999
Wednesday, November 6, 2024CANCELLATION TERMINATED NO. 999999
Monday, December 7, 2020TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, December 28, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 8, 2020SUSPENSION INQUIRY WRITTEN
Tuesday, November 12, 2019SUSPENSION LETTER WRITTEN
Wednesday, November 6, 2024CANCELLED SECTION 18-TOTAL
Monday, August 19, 2019NEW APPLICATION ENTERED
Saturday, August 31, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, June 8, 2020INQUIRY TO SUSPENSION E-MAILED
Monday, June 8, 2020NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Tuesday, November 12, 2019NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, February 2, 2021PUBLISHED FOR OPPOSITION
Tuesday, February 2, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 15, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 20, 2021REGISTERED-PRINCIPAL REGISTER
Monday, June 17, 2024CANCELLATION INSTITUTED NO. 999999
Wednesday, January 13, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, June 3, 2020ASSIGNED TO LIE
Tuesday, December 15, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 5, 2019ASSIGNED TO EXAMINER
Tuesday, November 12, 2019LETTER OF SUSPENSION E-MAILED
Wednesday, June 3, 2020SUSPENSION CHECKED - TO ATTORNEY FOR ACTION